A carregar...
What was lost in translation in the DHA trial is whom you should intend to treat
The results of a randomized double-blind placebocontrolled trial with docosahexaenoic acid (DHA) supplementation in mild to moderate Alzheimer's disease (AD) published by Quinn and colleagues in JAMA argues against overall efficacy of DHA in slowing progression. However, certain caveats in the...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3109411/ https://ncbi.nlm.nih.gov/pubmed/21251328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt61 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|